What Is Treatment-Resistant Depression?
Treatment-resistant depression is a form of depression in which symptoms do not improve significantly despite having tried several treatments. Although mental health is receiving increasing attention, it remains an area with significant gaps, especially in the Spanish public healthcare system, where access to professionals can involve long waiting lists.
Clinically, treatment-resistant depression (TRD) is diagnosed when a person does not respond adequately to at least two different antidepressant treatments administered over a sufficient period of time. This condition affects approximately 30% of people with major depressive disorder.
The most common treatments include selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). However, in cases of treatment-resistant depression, these approaches may not be sufficient.
Symptoms and consequences of treatment-resistant depression
Treatment-resistant depression can manifest with persistent symptoms such as:
- Prolonged low mood
- Lack of energy or motivation
- Difficulty concentrating
- Sleep problems
- Loss of interest in daily activities
Although some patients experience slight improvement, they do not achieve complete remission. These residual symptoms can severely affect quality of life and increase the risk of chronicity.
Furthermore, the process of trying multiple treatments without success can lead to frustration, emotional exhaustion, and a significant impact on personal and professional life.
Treatment options for treatment-resistant depression
Despite the challenges, there are various strategies for addressing treatment-resistant depression. It is essential to work with a mental health professional to evaluate each case individually.
Medication adjustments and psychotherapy
In many cases, the first step involves:
- Adjusting the antidepressant dose
- Switching medications
- Combining different medications
It is important to remember that antidepressants can take several weeks to take effect. Additionally, psychotherapy plays a key role as a complement to medication treatment.
Advanced therapies
In recent years, effective alternatives for treatment-resistant depression have emerged, such as:
- Transcranial magnetic stimulation (TMS)
- Vagus nerve stimulation (VNS)
These techniques can be particularly useful when conventional treatments do not work.
Psychedelic-Assisted Psychotherapy
One of the most promising areas in the treatment of treatment-resistant depression is the use of psychedelic-assisted psychotherapy, such as with psilocybin or ketamine.
Several recent studies suggest that these substances, when used in controlled clinical settings, can help reduce depressive symptoms, facilitate changes in thought patterns, and help process deep emotional experiences.
In some cases, such as with ketamine, it is not necessary to interrupt other treatments, which facilitates their integration into the therapeutic process.
Key Factors in Recovery
Treatment-resistant depression does not depend solely on biological factors. Chronic stress, lifestyle, and the social environment also play a significant role.
Therefore, incorporating healthy habits can enhance the effect of treatments:
- Regular physical exercise
- Stable sleep routines
- Relaxation techniques (meditation, yoga)
- Social support
- Reduced alcohol consumption
These changes do not replace clinical treatment, but they do serve as a fundamental support in recovery.
Conclusion: Can Treatment-Resistant Depression Be Overcome?
Treatment-resistant depression is a complex challenge, but that doesn’t mean there are no solutions. Thanks to advances in mental health, there are now more options than ever for addressing these cases.
With a comprehensive approach that combines medical treatment, psychological support, and lifestyle interventions, many people are able to significantly improve their quality of life. Seeking specialized help and not giving up along the way is key to finding the most appropriate treatment. That is why at Clinica Synaptica we use innovative treatments such as ketamine-assisted psychotherapy, which can offer new hope to those who have not seen results through other methods.
References
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982454/pdf/ndt-16-221.pdf
